Affentranger Associates

InflaRx N.V. is a clinical-stage biopharmaceutical company based in Jena, Germany, specializing in the development of therapeutics targeting inflammation through its proprietary C5a technology. This technology focuses on C5a, an inflammatory mediator linked to various autoimmune and inflammatory diseases. The company's lead product candidate, IFX-1, is a first-in-class anti-C5a monoclonal antibody administered intravenously, designed to treat conditions such as hidradenitis suppurativa, ANCA-associated vasculitis, and pyoderma gangrenosum, as well as potential applications in oncology. Additionally, InflaRx is developing IFX-2, which is currently in pre-clinical stages for chronic inflammation and autoimmune diseases. The company collaborates with Beijing Defengrei Biotechnology Co. Ltd. and was founded in 2007, previously operating under the name Fireman B.V. InflaRx aims to translate its research into effective clinical therapies for patients suffering from severe inflammatory conditions.

InflaRx N.V. is a clinical-stage biopharmaceutical company based in Jena, Germany, specializing in the development of therapeutics targeting inflammation through its proprietary C5a technology. This technology focuses on C5a, an inflammatory mediator linked to various autoimmune and inflammatory diseases. The company's lead product candidate, IFX-1, is a first-in-class anti-C5a monoclonal antibody administered intravenously, designed to treat conditions such as hidradenitis suppurativa, ANCA-associated vasculitis, and pyoderma gangrenosum, as well as potential applications in oncology. Additionally, InflaRx is developing IFX-2, which is currently in pre-clinical stages for chronic inflammation and autoimmune diseases. The company collaborates with Beijing Defengrei Biotechnology Co. Ltd. and was founded in 2007, previously operating under the name Fireman B.V. InflaRx aims to translate its research into effective clinical therapies for patients suffering from severe inflammatory conditions.

Selfrag AG is a Swiss company that specializes in the development and marketing of high voltage electric pulse generators and electric pulse disaggregation (EPD) systems. Founded in 2007, the company focuses on selective fragmentation of solid materials, providing innovative alternatives to conventional crushing and grinding techniques. Its product lineup includes laboratory systems for selective fragmentation, rod crushers for the solar and semiconductor industries, and modular equipment for transporting and fragmenting bulky materials like rock and concrete. Selfrag’s technologies aim to enhance the value of extracted or recycled materials while significantly reducing energy consumption, thus promoting sustainable practices in mineral processing. The company serves various sectors, including geosciences, recycling, and mining, and has over 40 installations worldwide. In addition to its products, Selfrag offers laboratory testing, service packages, and training to support its clients in optimizing their operations.

SIRS-Lab is a privately held diagnostic company developing unique and innovative products to identify and monitor life-threatening infections, one of the major causes of death in hospitals across the world. SIRS-Lab's vision is to support clinicians in their bedside decisions by providing them with fast and reliable high-performance point of care systems and thus, to improve therapeutic impact and reduce the mortality rate of patients. Founded in 2000 by S. Russwurm, K. Reinhart, E. Straube and H.-P. Saluz, SIRS-Lab employs today 45 people. The company currently commercializes VYOO, a molecular diagnostic test for the rapid identification of sepsis causing bacteria and fungi. Sepsis is one of the major causes of death in hospitals.

Dunes Technologies is devoted to providing a comprehensive, cost-effective set of software tools to efficiently manage virtual IT infrastructures. Dunes Technologies dramatically increases the IT operations performance by leveraging efficiencies that can only come from automation and helps to unleash the full power of Virtualization. Dunes Technologies was founded in 2000 and is headquartered in Vaud, Switzerland.